S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Final stage before digital money (Ad)
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Biden, GOP reach debt-ceiling deal, now Congress must approve it to prevent calamitous default
Sell every Stock except ONE (Ad)
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Final stage before digital money (Ad)
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Biden, GOP reach debt-ceiling deal, now Congress must approve it to prevent calamitous default
Sell every Stock except ONE (Ad)
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Final stage before digital money (Ad)
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Biden, GOP reach debt-ceiling deal, now Congress must approve it to prevent calamitous default
Sell every Stock except ONE (Ad)
S&P 500   4,205.45
DOW   33,093.34
QQQ   348.40
MarketBeat Week in Review – 5/22 - 5/26
Final stage before digital money (Ad)
New bill to build Athletics stadium on Las Vegas Strip caps Nevada's cost at $380 million
Baby eels remain one of America's most valuable fish after strong year in Maine
Sell every Stock except ONE (Ad)
'Succession' fans brace for series finale of Emmy-winning hit drama
Biden, GOP reach debt-ceiling deal, now Congress must approve it to prevent calamitous default
Sell every Stock except ONE (Ad)
NASDAQ:STRM

Streamline Health Solutions (STRM) Stock Forecast, Price & News

$1.55
+0.01 (+0.65%)
(As of 05/26/2023 ET)
Compare
Today's Range
$1.54
$1.55
50-Day Range
$1.54
$1.88
52-Week Range
$1.04
$2.35
Volume
1,719 shs
Average Volume
18,060 shs
Market Capitalization
$90.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$3.00

Streamline Health Solutions MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
93.5% Upside
$3.00 Price Target
Short Interest
Healthy
0.03% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
1.11mentions of Streamline Health Solutions in the last 14 days
Based on 4 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
N/A

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.32 out of 5 stars

Medical Sector

315th out of 1,018 stocks

Computer Integrated Systems Design Industry

17th out of 40 stocks


STRM stock logo

About Streamline Health Solutions (NASDAQ:STRM) Stock

Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. Its solutions include Health Information Management (HIM), Coding and CDI, evaluator coding analysis platforms, financial management, and patient care. It also offers audit, custom integration, training, electronic image conversion, and database monitoring services. The company was founded by J. Brian Patsy in October 1989 and is headquartered in Alpharetta, GA.

Receive STRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Streamline Health Solutions and its competitors with MarketBeat's FREE daily newsletter.

STRM Stock News Headlines

Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Sell every Stock except ONE
Markets are down...But Jeff Clark couldn't care less because he ignores almost every stock in the market except ONE. He lives financially free trading this One Stock Once per month...
Q4 2022 Streamline Health Solutions Inc Earnings Call
Streamline Health Stock Soars (STRM)
See More Headlines
Receive STRM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Streamline Health Solutions and its competitors with MarketBeat's FREE daily newsletter.

STRM Company Calendar

Last Earnings
4/27/2022
Today
5/27/2023
Next Earnings (Estimated)
6/14/2023
Fiscal Year End
1/31/2024

Industry, Sector and Symbol

Industry
Computer integrated systems design
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:STRM
Fax
N/A
Employees
66
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$3.00
High Stock Price Forecast
$3.00
Low Stock Price Forecast
$3.00
Forecasted Upside/Downside
+93.5%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
1 Analysts

Profitability

Net Income
$-11,380,000.00
Pretax Margin
-45.43%

Debt

Sales & Book Value

Annual Sales
$24.89 million
Book Value
$0.62 per share

Miscellaneous

Free Float
42,956,000
Market Cap
$90.85 million
Optionable
Not Optionable
Beta
1.29

Key Executives

  • Wyche Thomas Green
    Chairman & Chief Executive Officer
  • Ben Stilwill
    President
  • Thomas J. Gibson
    Chief Financial Officer & Senior Vice President
  • Lance Seach
    Senior Vice President-Business Development
  • Amy Sebero
    Chief Growth Officer













STRM Stock - Frequently Asked Questions

Should I buy or sell Streamline Health Solutions stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Streamline Health Solutions in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" STRM shares.
View STRM analyst ratings
or view top-rated stocks.

What is Streamline Health Solutions' stock price forecast for 2023?

1 brokerages have issued 1 year price targets for Streamline Health Solutions' shares. Their STRM share price forecasts range from $3.00 to $3.00. On average, they predict the company's stock price to reach $3.00 in the next twelve months. This suggests a possible upside of 93.5% from the stock's current price.
View analysts price targets for STRM
or view top-rated stocks among Wall Street analysts.

How have STRM shares performed in 2023?

Streamline Health Solutions' stock was trading at $1.58 at the beginning of 2023. Since then, STRM stock has decreased by 1.9% and is now trading at $1.55.
View the best growth stocks for 2023 here
.

Are investors shorting Streamline Health Solutions?

Streamline Health Solutions saw a drop in short interest in May. As of May 15th, there was short interest totaling 14,100 shares, a drop of 65.2% from the April 30th total of 40,500 shares. Based on an average daily volume of 41,800 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.0% of the shares of the company are short sold.
View Streamline Health Solutions' Short Interest
.

When is Streamline Health Solutions' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 14th 2023.
View our STRM earnings forecast
.

How were Streamline Health Solutions' earnings last quarter?

Streamline Health Solutions, Inc. (NASDAQ:STRM) released its quarterly earnings data on Wednesday, April, 27th. The company reported ($0.06) earnings per share (EPS) for the quarter, meeting analysts' consensus estimates of ($0.06). The company had revenue of $6.05 million for the quarter. Streamline Health Solutions had a negative net margin of 45.72% and a negative trailing twelve-month return on equity of 35.11%. During the same period last year, the company posted ($0.05) earnings per share.

What is David Sides' approval rating as Streamline Health Solutions' CEO?

31 employees have rated Streamline Health Solutions Chief Executive Officer David Sides on Glassdoor.com. David Sides has an approval rating of 82% among the company's employees.

What other stocks do shareholders of Streamline Health Solutions own?
What is Streamline Health Solutions' stock symbol?

Streamline Health Solutions trades on the NASDAQ under the ticker symbol "STRM."

Who are Streamline Health Solutions' major shareholders?

Streamline Health Solutions' stock is owned by many different institutional and retail investors. Top institutional investors include Punch & Associates Investment Management Inc. (2.47%), BlackRock Inc. (0.73%), Geode Capital Management LLC (0.62%), UBS Group AG (0.58%), Renaissance Technologies LLC (0.48%) and Boothbay Fund Management LLC (0.32%). Insiders that own company stock include Global Healthcare Fun Tamarack and Kenan Lucas.
View institutional ownership trends
.

How do I buy shares of Streamline Health Solutions?

Shares of STRM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Streamline Health Solutions' stock price today?

One share of STRM stock can currently be purchased for approximately $1.55.

How much money does Streamline Health Solutions make?

Streamline Health Solutions (NASDAQ:STRM) has a market capitalization of $90.85 million and generates $24.89 million in revenue each year. The company earns $-11,380,000.00 in net income (profit) each year or ($0.24) on an earnings per share basis.

How can I contact Streamline Health Solutions?

Streamline Health Solutions' mailing address is 11800 AMBER PARK DRIVE - SUITE 125, ALPHARETTA GA, 30009. The official website for the company is www.streamlinehealth.net. The company can be reached via phone at (888) 997-8732 or via email at randy.salisbury@streamlinehealth.net.

This page (NASDAQ:STRM) was last updated on 5/28/2023 by MarketBeat.com Staff

My Account -